Crotylation versus Propargylation:  Two Routes for the Synthesis of the C13−C18 Fragment of the Antibiotic Branimycin von Felzmann, Wolfgang, Castagnolo, Daniele, Rosenbeiger, Daniela, Mulzer, Johann

Volltext

One-step labelling of sphingolipids via a scrambling cross-metathesis reaction von Nussbaumer, Peter, Ettmayer, Peter, Peters, Carsten, Rosenbeiger, Daniela, Högenauer, Klemens

Volltext

One-Step Labelling of Sphingolipids via a Scrambling Cross-Metathesis Reaction von Nussbaumer, Peter, Ettmayer, Peter, Peters, Carsten, Rosenbeiger, Daniela, Hoegenauer, Klemens

Volltext

Peginterferon Alfa-2a and Ribavirin for 24 Weeks in Hepatitis C Type 1 and 4 Patients With Rapid Virological Response von Ferenci, Peter, Laferl, Hermann, Scherzer, Thomas–Matthias, Gschwantler, Michael, Maieron, Andreas, Brunner, Harald, Stauber, Rudolf, Bischof, Martin, Bauer, Bernhard, Datz, Christian, Löschenberger, Karin, Formann, Elisabeth, Staufer, Katharina, Steindl–Munda, Petra

Volltext

Peginterferon Alfa-2a/Ribavirin for 48 or 72 Weeks in Hepatitis C Genotypes 1 and 4 Patients With Slow Virologic Response von Ferenci, Peter, Laferl, Hermann, Scherzer, Thomas–Matthias, Maieron, Andreas, Hofer, Harald, Stauber, Rudolf, Gschwantler, Michael, Brunner, Harald, Wenisch, Christoph, Bischof, Martin, Strasser, Michael, Datz, Christian, Vogel, Wolfgang, Löschenberger, Karin, Steindl–Munda, Petra

Volltext

A randomized, prospective trial of ribavirin 400 mg/day versus 800 mg/day in combination with peginterferon alfa‐2a in hepatitis C virus genotypes 2 and 3 von Ferenci, Peter, Brunner, Harald, Laferl, Hermann, Scherzer, Thomas‐Matthias, Maieron, Andreas, Strasser, Michael, Fischer, Gabriele, Hofer, Harald, Bischof, Martin, Stauber, Rudolf, Gschwantler, Michael, Steindl‐Munda, Petra, Staufer, Katharina, Löschenberger, Karin

Volltext